Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behavior

This study demonstrates that maternally administered LSD rapidly crosses into the embryonic cerebrospinal fluid within minutes, acutely activates the choroid plexus, and leads to lasting alterations in cortical development and adult offspring behavior in mice.

The Gist

The Big Picture: A "Fast-Track" Delivery System

Imagine a pregnant mother taking a psychedelic drug (like LSD). The big question scientists had was: How fast does that drug get to the baby's brain, and does the baby's brain even notice it?

Usually, we think of the placenta as a strict security guard that keeps bad things out. But this study found that for LSD, the security guard is actually a revolving door. The drug doesn't just sneak in slowly; it zooms through the placenta and arrives in the baby's brain fluid (Cerebrospinal Fluid or CSF) in less than 5 minutes. That's faster than it takes to brew a cup of coffee.

The "Brain's Mailroom": The Choroid Plexus

To understand what happens next, you have to meet the Choroid Plexus (ChP).

Think of the developing brain as a giant, growing city. The CSF is the river of water flowing through the city's streets, carrying nutrients and messages. The Choroid Plexus is the central mailroom and water treatment plant sitting right on the banks of that river. Its job is to make the river water and decide what gets sent out to the rest of the city.

This study discovered that the ChP is packed with "receptors" (like mail slots) specifically designed to catch serotonin-based drugs. When the mother takes LSD, the drug rushes into the baby's river (CSF) and immediately hits the mailroom.

What happens when the mailroom gets hit?

1. The Alarm Rings: Within 30 minutes, the cells in the mailroom scream "We've got mail!" (Scientists saw this as a protein called Fos lighting up).
2. The Doors Change Shape: The mailroom workers physically change their shape, stretching out little fingers to push more stuff into the river.
3. The River Changes: The chemical makeup of the baby's brain fluid changes almost instantly.

This happened not just with LSD, but also with other psychedelics like psilocybin (magic mushrooms) and even a drug that only targets one specific type of serotonin receptor. It seems the "mailroom" is very sensitive to these chemicals.

The Long-Term Effects: A Construction Site Left in Chaos

The researchers then asked: If we mess with the mailroom during construction, does the finished building look different?

They looked at baby mice (at 8 days old) and adult mice (grown-ups) whose mothers took LSD while pregnant.

1. The Baby Mice (The Construction Site):
The brain's "construction site" (the cortex) looked a bit off.

• Fewer Workers: There were fewer total brain cells.
• Wrong Blueprints: The brain cells that were supposed to be "callosal neurons" (the ones that connect the left and right sides of the brain) were missing. Instead, there were too many "subcerebral neurons" (the ones that send signals out to the body).
• The Cleanup Crew: The brain's janitors (microglia) were working overtime, suggesting the brain was stressed or trying to fix something.
• Gender Difference: Interestingly, the male baby mice showed more of these changes than the females.

2. The Adult Mice (The Finished Building):
When these mice grew up, they acted differently.

• The "Spin Cycle": They started spinning in circles over and over again. It wasn't just walking around; it was a repetitive, obsessive behavior.
• The "Startle" Test: When they heard a loud noise, they didn't react as well as normal mice. This is called "sensory gating"—the ability to filter out background noise. If you can't filter noise, your brain gets overwhelmed.
• Who was affected? The males who had been exposed to repeated doses of LSD showed the biggest issues with filtering noise.

The Takeaway: A Warning and a Discovery

The Warning:
If a pregnant person uses psychedelics, the drug hits the baby's brain fluid almost instantly. It doesn't just sit there; it actively wakes up the brain's "mailroom," changing the chemical environment while the brain is still being built. This can lead to permanent changes in how the brain is wired, resulting in repetitive behaviors and trouble filtering sensory information later in life.

The Discovery:
This study gave us a new map. We now know that the Choroid Plexus is a major target for these drugs during pregnancy. It's not just the brain cells themselves that get hit; it's the system that feeds the brain.

In a nutshell:
Imagine the mother's drug is a sudden, powerful storm. The baby's brain is a house under construction. This study shows that the storm doesn't just rain on the roof; it floods the basement (the CSF) and immediately jams the main water pump (the Choroid Plexus). Even after the storm passes, the house is built with a few missing bricks and a plumbing system that makes the residents act a little strangely for the rest of their lives.

Technical Summary

1. Problem Statement

The use of classic serotonergic psychedelics during pregnancy is increasing, yet the mechanisms by which these compounds access the developing embryonic brain remain poorly defined. Specifically, it is unknown:

• Whether maternally administered psychedelics cross the placenta to reach the embryonic cerebrospinal fluid (CSF).
• Whether the embryonic choroid plexus (ChP)—a CSF-secreting epithelium rich in serotonin receptors (specifically 5-HT2C)—mounts an acute response to these ligands.
• Whether mid-gestational exposure alters cerebral cortical development and leads to persistent behavioral deficits in offspring.

2. Methodology

The study utilized a multi-modal approach combining pharmacokinetics, molecular biology, histology, and behavioral neuroscience in a murine model (CD-1 mice).

• Pharmacokinetics (PK) & Drug Delivery:

  • Subjects: Timed-pregnant dams received subcutaneous injections of LSD (0.3 mg/kg), psilocybin (3 mg/kg), 5-MeO-DMT (50 mg/kg), or the selective 5-HT2C agonist WAY-161503 (3 mg/kg).
  • Sampling: Maternal serum, embryonic serum (E16.5), and embryonic CSF (E12.5 and E16.5) were collected at 5, 15, 30, 60, and 120 minutes post-injection.
  • Quantification: A sensitive LC–MS/MS assay was developed to quantify LSD in small-volume samples (limit of quantitation: 0.25 ng/mL).

• Choroid Plexus (ChP) Response Assays:

  • Transcriptional: Microdissected ChP tissue was analyzed via RT-qPCR for Fos (immediate early gene) expression 30 minutes post-dosing.
  • Structural/Functional: Immunostaining for c-FOS and phalloidin/ezrin (to visualize apical remodeling/aposomes) was performed on ChP explants and whole-mount cleared embryos (using light-sheet microscopy).
  • CSF Composition: Total protein concentration in embryonic CSF was measured 30 minutes post-dosing.

• Developmental & Behavioral Cohorts:

  • Exposure Regimens: Dams received either a single acute dose at E12.5 or repeated daily doses from E12.5–E16.5.
  • Histology (P8): Postnatal day 8 (P8) brains were analyzed for cortical cellularity (DAPI), projection neuron subtype composition (SATB2+, CTIP2+, TBR1+), and glial markers (IBA1 for microglia, GFAP for astrocytes).
  • Behavior (P90): Adult offspring underwent Prepulse Inhibition (PPI) testing and Open Field tests to assess sensorimotor gating and stereotypy.

3. Key Contributions

• Rapid Placental Transfer: Demonstrated that maternally administered LSD crosses the placenta and enters embryonic CSF within 5–15 minutes.
• ChP as a Primary Target: Identified the embryonic choroid plexus as a rapidly responsive interface that undergoes acute transcriptional (Fos), structural (apical remodeling), and secretory (increased CSF protein) changes upon exposure to serotonergic agonists.
• Regimen- and Sex-Dependent Effects: Mapped specific alterations in cortical neuron subtype composition at P8 and persistent behavioral phenotypes in adulthood, highlighting significant sex-biased outcomes.

4. Key Results

A. Pharmacokinetics: Rapid Access to Embryonic CSF

• Following a single maternal dose, LSD was detectable in embryonic CSF within 5–15 minutes at both E12.5 and E16.5.
• Concentrations: At 15 minutes, embryonic CSF levels peaked at ~15.2 ng/mL (E12.5) and ~28.4 ng/mL (E16.5).
• Exposure: Embryonic serum exposure was ~17% of maternal levels; CSF exposure at E16.5 was ~1.4× higher than at E12.5.

B. Acute Choroid Plexus Activation

• Transcriptional: Maternal dosing with LSD, psilocybin, 5-MeO-DMT, or WAY-161503 induced rapid Fos expression in the ChP (LV, 3V, 4V) within 30 minutes.
• Structural: Epithelial cells exhibited increased aposome formation (actin-rich secretory protrusions), indicating an apocrine-like secretory state.
• Secretory: Total protein concentration in embryonic CSF increased significantly 30 minutes post-exposure, suggesting altered CSF composition.

C. Cortical Developmental Alterations (P8)

• Cellularity: Both acute and repeated exposure reduced total DAPI+ nuclei density in the S1 cortex (acute caused a larger deficit: 21–49% reduction).
• Neuron Subtypes:
  • SATB2+ (Callosal): Significantly reduced in both regimens (acute: -22.9 pp; repeated: -13.6 pp).
  • TBR1+ (Corticothalamic): Reduced in both regimens.
  • CTIP2+ (Subcerebral): Increased fraction only in males following repeated exposure (+8.4 pp).
• Sex Specificity: A significant Treatment × Sex × Bin interaction was found. Males showed robust shifts in SATB2+ and CTIP2+ populations, whereas females showed no detectable shifts in these specific markers.
• Glial Response: Microglial density (IBA1+) increased with repeated dosing (+22%).

D. Adult Behavioral Phenotypes (P90)

• Sensorimotor Gating (PPI): Prenatal LSD exposure reduced PPI. This effect was male-predominant and most robust in the repeated exposure group.
• Stereotypy: Offspring exhibited a significant increase in rotational stereotypy in the open field (acute: 136 rotations vs. control 54). "High-rotators" were more frequent in LSD groups.
• Other Findings:
  • Elevated baseline stereotypy (backflipping, tight circling) persisted from weaning (P21) through adulthood.
  • Ventriculomegaly (frontal horn predominance) was observed in 9/10 acute and 8/10 repeated exposure mice at P156.
  • Higher-order behaviors (social approach, novel object recognition) were uninterpretable due to the confounding elevated stereotypy.

5. Significance

• Mechanistic Insight: The study establishes that the embryonic CSF-ChP interface is a rapidly accessible compartment for maternal serotonergic drugs, challenging the notion that the embryonic brain is fully shielded from such exposures during mid-gestation.
• Developmental Vulnerability: It highlights that the ChP, via its high density of 5-HT2C receptors, acts as a sensor that translates maternal drug exposure into acute changes in CSF composition and downstream cortical development.
• Clinical Relevance: While the doses used are not human-equivalent, the findings suggest that maternal psychedelic use could potentially disrupt neurodevelopmental trajectories, leading to sex-specific alterations in cortical circuitry and behavioral phenotypes (specifically stereotypy and sensorimotor gating deficits).
• Future Directions: The authors propose a working model where ChP activation alters the CSF molecular environment, influencing cortical progenitor behavior. They call for future studies involving receptor perturbation (e.g., antagonism) to confirm causality and receptor-specific pathways.